Blocking Stroke-Induced Immunodeficiency Increases CNS Antigen-Specific Autoreactivity But Does Not Worsen Functional Outcome after Experimental Stroke
Christine Römer(Institute of Clinical and Experimental Medicine), Andreas Meisel(Humboldt-Universität zu Berlin)
Cited by 76
Related Papers
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use
|The Lancet Neurology|2009|581
Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
|PubMed|2002|452
Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an<i>In Vitro</i>Model
|Journal of Neuroscience|2002|387
Mental health in myasthenia gravis patients and its impact on caregiver burden
|Scientific Reports|2022|36